#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune disorder Hepatic angiosarcoma Congenital leptin deficiency Gastrointestinal stromal tumour Pseudoxanthoma elasticum Hairy cell leukaemia Diffuse large B-cell lymphoma Palmar-plantar erythrodysaesthesia syndrome Haemolytic uraemic syndrome Urethral valves Palmoplantar pustulosis Focal segmental glomerulosclerosis Myotonic dystrophy Pseudomyxoma peritonei Juvenile psoriatic arthritis More trials…

    Learn about Rare Diseases

    Friedreich’s ataxia – Basic Information Haemophilia B with anti factor IX – Diagnostics Niemann-Pick disease – Treatment Systemic sclerosis pulmonary Ehlers-Danlos syndrome Rett syndrome – Treatment Progressive multifocal leukoencephalopathy – Diagnostics Pulmonary sarcoidosis – Trials in Disease IgA nephropathy – Trials in Disease Chronic granulomatous disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mbs2320 Propranolol Dolutegravir Sodium Pertechnetate (99Mtc) Sodium Raludotatug Deruxtecan Protamine Sulfate Savolitinib Gabapentin Pasireotide Bi-1808 Rifabutin Deferoxamine Lebrikizumab Cagrilintide Imlifidase 64CU-PSMA I&T Seladelpar Festuca Elatior Pollen Extract Ertapenem Tirzepatide More therapies…

    Learn about Your Condition

    Pneumonia bacterial Chronic myeloid leukaemia Bronchopulmonary aspergillosis Dyslipidaemia Postprandial hypoglycaemia Pancreatic fistula Connective tissue disorder Incontinence Meniere's disease Pyelonephritis acute Pancoast's tumour Biliary neoplasm Glomerulonephritis membranous Delayed graft function Ependymoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Iceland

  • Study on JDQ443 and Docetaxel for Patients with Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • 1-{6-[(4M)-4-(5-Chloro-6-Methyl-1H -Indazol-4-Yl)-5-Methyl-3-(1-Methyl-1H -Indazol-5-Yl)-1H -Pyrazol-1-Yl]-2-Azaspiro[3.3]Heptan-2-Yl}Prop-2-En-1-One
    • Docetaxel
    Finland Greece Hungary Iceland Italy Portugal +3

  • Study Comparing Conventional Therapy and Biologic Treatments for Early Rheumatoid Arthritis Using Hydroxychloroquine, Abatacept, and Azathioprine in Responsive Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Triamcinolone Hexacetonide
    • Certolizumab Pegol
    • Leflunomide
    Denmark Iceland Norway Sweden

  • Study on the Safety and Effects of Acetylcysteine Amide for Patients Aged 12 and Over with Hereditary Cystatin C Amyloid Angiopathy

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cerebral amyloid angiopathy
    Investigated Drugs:
    • Acetylcysteine Amide
    Iceland

  • A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

    Not recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

  • Study on the Safety and Effects of NPI-001 (Acetylcysteine Amide) for Patients Aged 50-85 with Mild Cognitive Impairment or Mild Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Drugs:
    • Acetylcysteine Amide
    Denmark Iceland

  • Study on the Safety and Effectiveness of Saroglitazar Magnesium for Patients with Primary Biliary Cholangitis

    Not recruiting

    4 1
    Investigated Drugs:
    • SAROGLITAZAR HEMIMAGNESIUM
    Iceland
Previous Page
1 2 3 4 5
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Acetylcysteine Amide Cytarabine Pelacarsen Aficamten Lenalidomide Dexamethasone Prednisolone Sodium Succinate Methotrexate Methylprednisolone Tafasitamab Blinatumomab Certolizumab Pegol Secukinumab Terbinafine Etoposide Rituximab Leflunomide Apixaban Terbinafine Hydrochloride Fludarabine Phosphate SAROGLITAZAR HEMIMAGNESIUM Imatinib Abatacept Quizartinib Dihydrochloride Mitomycin MAGNESIUM CARBONATE HEAVY Hydrocortisone Sodium Succinate Methotrexate Sodium Durvalumab Carfilzomib Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute lymphocytic leukaemia Acute myeloid leukaemia Arteriosclerosis Atrial fibrillation Bladder transitional cell carcinoma Breast cancer Cerebral amyloid angiopathy Chronic kidney disease Coronary artery disease Dyslipidaemia Dyspepsia End stage renal disease Follicular lymphoma Hypertrophic cardiomyopathy Infertility Intensive care Non-small cell lung cancer Plasma cell myeloma Primary biliary cholangitis Rheumatoid arthritis Small cell lung cancer extensive stage Transitional cell carcinoma

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!